nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis, statistical validation and dissemination of large-scale proteomics datasets generated by tandem MS
|
Nesvizhskii, Alexey I |
|
2004 |
9 |
4 |
p. 173-181 9 p. |
artikel |
2 |
Biological basis for the benefit of nutraceutical supplementation in arthritis
|
Curtis, Clare L |
|
2004 |
9 |
4 |
p. 165-172 8 p. |
artikel |
3 |
High-throughput molecular pathology in human tissues as a method for driving drug discovery
|
Beesley, Julian |
|
2004 |
9 |
4 |
p. 182-189 8 p. |
artikel |
4 |
Monitor – Biology
|
Heath, Victoria |
|
2004 |
9 |
4 |
p. 191-193 3 p. |
artikel |
5 |
Monitor – Business
|
Clough, Joanne |
|
2004 |
9 |
4 |
p. 193-194 2 p. |
artikel |
6 |
Monitor – Chemistry
|
Westwell, Andrew D |
|
2004 |
9 |
4 |
p. 190- 1 p. |
artikel |
7 |
Monitor – People
|
Owens, Joanna |
|
2004 |
9 |
4 |
p. 194-195 2 p. |
artikel |
8 |
More PPPs for drugs please
|
Carey, Jayne |
|
2004 |
9 |
4 |
p. 155-156 2 p. |
artikel |
9 |
Neurogenomics of mice and men
|
Keegan, Nina |
|
2004 |
9 |
4 |
p. 157-158 2 p. |
artikel |
10 |
Pharmaceutical companies liable for fraudulent research by subcontractors
|
Nolan, Kenneth J |
|
2004 |
9 |
4 |
p. 153-154 2 p. |
artikel |
11 |
Prediction of blood–brain barrier penetration: are we missing the point?
|
Martin, Iain |
|
2004 |
9 |
4 |
p. 161-162 2 p. |
artikel |
12 |
Robin Ganellin gives his views on medicinal chemistry and drug discovery
|
Ganellin, C.Robin |
|
2004 |
9 |
4 |
p. 158-160 3 p. |
artikel |
13 |
Sea squirt sheds light on advanced soft tissue sarcomas
|
Moyer, Paula |
|
2004 |
9 |
4 |
p. 156-157 2 p. |
artikel |
14 |
Stacking up the armory against viruses
|
Klebl, Bert M |
|
2004 |
9 |
4 |
p. 162-164 3 p. |
artikel |